Table 5.
Variables |
< 40 years old |
≥ 40 years old |
||
---|---|---|---|---|
OR(IC) | p-value | OR(CI) | p-value | |
Age (continuous) |
1.12 (1.05 – 1.20) |
0.001 |
1.11 (1.05 – 1.17) |
< 0.001 |
Male sex |
2.77 (1.43 – 5.34) |
0.002 |
1.62 (0.94 – 2.81) |
0.080 |
Nonwhite |
3.01 (1.23 - 6.53) |
0.007 |
1.37 (0.73 – 2.57) |
0.321 |
BMI overweight |
1.65 (0.79 – 3.44) |
0.344 |
1.93 (1.04 – 3.57) |
0.036 |
Obese |
5.13 (1.79 – 14.7) |
0.002 |
2.53 (0.85 – 7.54) |
0.095 |
Metabolic Syndrome |
3.30 (1.44 – 7.58) |
0.005 |
1.01 (0.54 – 1.88) |
0.968 |
Total cholesterol <200 |
1.0 |
|
1.0 |
|
200 to < 240 mg/dL |
0.83 (0.32 - 2.03) |
0.701 |
1.24 (0.66 – 2.32) |
0.491 |
≥ 240 mg/dL |
2.28 (0.83 – 9.40) |
0.095 |
2.14 (0.76 – 5.98) |
0.145 |
Stable partner |
2.07 (1.03 – 4.19) |
0.041 |
2.41 (1.24 – 4.67) |
0.009 |
CD4+ T-lymphocytes <200 |
1.0 |
|
1.0 |
|
200 to < 350 cels/mm3 |
0.86 (0.33 – 2.24) |
0.758 |
1.18 (0.59 – 2.37) |
0.631 |
≥ 350 cels/mm3 |
0.71 (0.24 – 2.09) |
0.542 |
2.81 (1.22 – 6.47) |
0.015 |
HAART duration of use |
|
|
|
|
No HAART use |
1.0 |
|
1.0 |
|
PI < 5 years |
0.64 (0.27 – 1.54) |
0.323 |
0.67 (0.32 – 1.39) |
0.287 |
PI ≥ 5 years |
2.15 (0.23 – 20.1) |
0.503 |
1.81 (0.38 – 8.59) |
0.453 |
NNRTI < 5 years |
1.52 (0.74 – 3.08) |
0.248 |
1.31 (0.66 – 2.60) |
0.426 |
NNRTI ≥ 5 years | 1.94 (0.62 – 6.07) | 0.254 | 2.65 (1.10 – 6.37) | 0.028 |